Single cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib. Blood Purroy Zuriguel, N., Tong, Y. E., Lemvigh, C. K., Cieri, N., Li, S., Parry, E. M., Zhang, W., Rassenti, L. Z., Kipps, T. J., Slager, S. L., Kay, N. E., Lesnick, C., Shanafelt, T. D., Ghia, P., Scarfò, L., Livak, K. J., Kharchenko, P. V., Neuberg, D., Olsen, L. R., Fan, J., Gohil, S. H., Wu, C. J. 2022

View details for DOI 10.1182/blood.2021013926

View details for PubMedID 35020831